A rating of 85 puts Evogene Ltd (EVGN) near the top of the Biotechnology industry according to InvestorsObserver. Evogene Ltd's score of 85 means it scores higher than 85% of stocks in the industry. Evogene Ltd also received an overall rating of 66, putting it above 66% of all stocks. Biotechnology is ranked 28 out of the 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 66 means the stock is more attractive than 66 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Evogene Ltd (EVGN) stock is trading at $2.82 as of 11:50 AM on Wednesday, Sep 2, an increase of $0.08, or 2.92% from the previous closing price of $2.74. Volume today is elevated. So far 1,124,639 shares have traded compared to average volume of 361,387 shares. The stock has traded between $2.47 and $2.95 so far today.

Click Here to get the full Stock Score Report on Evogene Ltd (EVGN) Stock.

Read more here:
Is Evogene Ltd (EVGN) The Right Choice in Biotechnology? - InvestorsObserver